SCHEMBL344616

SCHEMBL344616

O=C(OCCCO)c1ccccc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.81
LMNA P02545 3/20 0.63
ALDH1A1 P00352 1/20 0.58
MAPK1 P28482 2/20 0.55
HIF1A Q16665 1/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A3 Q01959 1/20 0.55
KMT2A Q03164 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.51
TSHR P16473 2/20 0.50
ESR1 P03372 2/20 0.50
F2 P00734 1/20 0.50
ESR2 Q92731 1/20 0.50
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
NR1H2 P55055 1/20 0.49
RNASEL Q05823 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL49966 0.94 TDP1 (0.85) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL26189844 0.93 TDP1 (0.70) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL11896258 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL10790013 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL11896278 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL6821603 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL14723101 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL9712789 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL7295237 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A
SCHEMBL28067101 0.92 TDP1 (0.81) TDP1LMNAALDH1A1MAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743053-A1 ANTIMICROBIAL SYNERGIES Symrise AG (DE) 2026-05-20 EP claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
EP-4554551-A1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS Symrise AG (DE) 2025-05-21 EP claimed
CN-119604270-A Comprising an antimicrobial agent accelerator composition 西姆莱斯股份公司 2025-03-11 CN claimed
WO-2025011739-A1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2025-01-16 WO claimed
WO-2025012262-A1 ANTIMICROBIAL SYNERGIES SYMRISE AG (DE) 2025-01-16 WO claimed
WO-2025012263-A1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2025-01-16 WO claimed
WO-2025011743-A1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL ACTIVES SYMRISE AG (DE) 2025-01-16 WO claimed
CN-118141701-A Composition containing benzoic acid derivative or furoic acid derivative and use of the derivative for emulsion and foam stability 西姆莱斯股份公司 2024-06-07 CN claimed
CN-111194206-B Composition containing benzoic acid derivative or furoic acid derivative and use of the derivative for emulsion and foam stability 西姆莱斯股份公司 2024-02-23 CN claimed
EP-2598472-A2 FORMULATIONS Syngenta Limited (GB) 2013-06-05 EP claimed
CN-103025704-A Formulations SYNGENTA LTD 2013-04-03 CN claimed
WO-2012014152-A2 FORMULATIONS SYNGENTA LIMITED (GB) 2012-02-02 WO claimed
CN-1814655-B Polyurethane for absorbing ultraviolet radiation GOLDSCHMIDT CO LTD 2010-09-01 CN claimed
CN-101111566-A Siloxanes comprising guanidino groups and use thereof for cosmetic formulations GOLDSCHMIDT GMBH (DE) 2008-01-23 CN claimed
CN-1814655-A Polyurethane for absorbing ultraviolet radiation GOLDSCHMIDT CO LTD (DE) 2006-08-09 CN claimed
CN-1193751-C Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives KOREA INST ORIENTAL MEDICINE (KR) 2005-03-23 CN claimed
CN-1383381-A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives KOREA INST ORIENTAL MEDICINE (KR) 2002-12-04 CN claimed
WO-1990000859-A1 INSECT REPELLANT NELSON & ROBERTSON PTY. LTD. (AU) 1990-02-08 WO claimed
EP-0200024-A2 3-Cyano-pyridines, process for their preparation and their pharmaceutical use ARZNEIMITTELWERK DRESDEN GmbH (DE) 1986-11-05 EP claimed